Steve Wallace

Steve joined ImmunArray in January 2013 and transitioned to BBS as the company was spun out of ImmunArray.

He brings more than 30 years of R&D and operations experience in the biotechnology, pharmaceutical and chemical industries to the company.

His expertise in small molecule and recombinant protein drug development includes process development, manufacturing, quality regulatory submissions, strategic planning, and financial analysis.